In The News

Stanford spinout developing surgical site wound care snags $6M

vision

Prescient Surgical, a Bay Area wound care startup that aims to reduce surgical site infection, has raised about $6 million, according to a regulatory filing.

The company’s staying pretty vague about the technology’s specifics, but president Jonathon Coe has said the company has “developed a platform technology that integrates fluid delivery with a novel wound retraction and protection system.” It’s undergoing clinical trials.

Studies have shown that surgical site infection costs about $21,000 on average to treat, increasing hospital stays by about 10 days. While overall about 2 to 5 percent of those undergoing inpatient surgery get these infections, that rate can rise up to 26 percent with abdominal GI operations like colorectal surgery, Prescient said.

VIP Guest: Prescient Surgical

vision

We have shared several posts where we get to know some of the influencers who will be at RxUX. Today we’ll introduce you to Jonathan Coe, the COO of Prescient Surgical. His company focuses on reducing the incidence of surgical site infections. We spoke to Jon about what he’s doing.

The making of an icon | Dr. Tom Fogarty's 'Fog Shop'

Fogarty Institute for Innovation logo

It's been 50 years since Dr. Tom Fogarty invented the catheter-based treatment for blood clots that's now the standard of care. At 80, it would be a cinch for Fogarty to retire to his California vineyard and bask in the reflected glory of his accomplishments.

But Fogarty, a serial entrepreneur with more than 30 medical device startups under his belt, told MassDevice.com recently that he has no plans to slow down until he's 6 feet under.

In Part 2 of our 3-part series, Fogarty takes us on a tour of The Fogarty Institute for Innovation, affectionately known as "The Fog Shop."

California non-profit picks up new class of startups hoping to (finally) transform women’s health

Fogarty Institute for Innovation logo

Five startups have been selected to join the incubator program at The Fogarty Institute, an education nonprofit based in Mountain Valley, Calif., that mentors medical innovators.

Four out of five of these companies–First Pulse Medical, Materna Medical, InPress Technologies and Medical Cue–are attempting to innovate in the maternity/women’s health field.

President and CEO Ann Fyfe said this is a growing trend, as lots of innovations need to be made but haven’t been, partially due to an environment surrounded by litigation that makes innovators and investors nervous.

The other one, Prescient Surgical, has two buzz words associated with it: readmissions and wound healing. Fyfe said the woundcare field is growing quickly, especially for those products intended to reduce hospital-acquired infections (in theory limiting hospital stays and readmissions).

Making pregnancy safer, one medtech start-up at a time

vision

Not every 79-year-old surgeon happens to run a tech incubator. Not every 79-year-old surgeon who runs a tech incubator happens to have a winery either. But Thomas Fogarty does. The doctor-entrepreneur-vintner, best known for inventing the angioplasty balloon, runs the Thomas Fogarty Winery just a few miles uphill from his medtech incubator at El Camino Hospital in Mountain View.

The non-profit Fogarty Institute for Innovation is based around a simple concept: Making life easier for small or early stage medtech firms developing cutting-edge products or tools. In an interview with Fast Company, Fogarty decried what he saw as the increasing cost of American medical innovation, and said that small medical companies need a safe environment for growth similar to those of lower-overhead conventional tech startups.